ReviewOntario health technology assessment series2012
Long-term oxygen therapy for patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis.
Review in Ontario health technology assessment series, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells (AD-cSVF) in Chronic Lung Disorders
Use of Autologous Stem/Stromal Cells in Chronic Lung Disorders: Obstructive (COPD) and Restrictive (RLD)
Who cites it
9 citing papers in PubMed.
- The Efficacy of High-Flow Nasal Cannula (HFNC) Treatment in Patients with Chronic Type II Respiratory Failure Secondary to COPD.Journal of clinical medicine · 2026Article
- Trends in pulmonary exercise testing utilization after the COVID-19 pandemic in Ontario: A population-cohort study.PloS one · 2026Article
- Impact of smoking, COPD and comorbidities on the mortality of COVID-19 patients.Scientific reports · 2021Article
- Management of lung disease in alpha-1 antitrypsin deficiency: what we do and what we do not know.Therapeutic advances in chronic disease · 2021Review
- Chronic obstructive pulmonary disease: moving from symptom relief to mortality reduction.Therapeutic advances in chronic disease · 2021Review
- Oxygen, the lung and the diver: friends and foes?European respiratory review : an official journal of the European Respiratory Society · 2016Review
- The pharmacological approach to the elderly COPD patient.Drugs & aging · 2013Review
- The clinical and economic burden of chronic obstructive pulmonary disease in the USA.ClinicoEconomics and outcomes research : CEOR · 2013Article
- Health technologies for the improvement of chronic disease management: a review of the Medical Advisory Secretariat evidence-based analyses between 2006 and 2011.Ontario health technology assessment series · 2013Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
23074435PMC3384376What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.